101 related articles for article (PubMed ID: 8564384)
1. In vitro and in vivo comparative studies on chelation of aluminum by some polyaminocarboxylic acids.
Graff L; Muller G; Burnel D
Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):271-92. PubMed ID: 8564384
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of potential aluminum chelators.
Graff L; Muller G; Burnel D
Vet Hum Toxicol; 1995 Oct; 37(5):455-61. PubMed ID: 8592836
[TBL] [Abstract][Full Text] [Related]
3. The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of aluminum intoxication than does desferrioxamine.
Yokel RA; Meurer KA; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1996 Jan; 24(1):105-11. PubMed ID: 8825197
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum.
Yokel RA; Datta AK; Jackson EG
J Pharmacol Exp Ther; 1991 Apr; 257(1):100-6. PubMed ID: 2019981
[TBL] [Abstract][Full Text] [Related]
5. Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine.
Yokel RA
J Toxicol Environ Health; 1994 Feb; 41(2):131-74. PubMed ID: 8301696
[TBL] [Abstract][Full Text] [Related]
6. Chelation in metal intoxication X: Influence of different polyaminocarboxylic acids and thiol chelators in the excretion and tissue distribution of 54Mn in rat.
Tandon SK; Khandelwal S
Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):337-40. PubMed ID: 7100634
[TBL] [Abstract][Full Text] [Related]
7. Chelating effect of novel pyrimidines in a model of aluminum intoxication.
Missel JR; Schetinger MR; Gioda CR; Bohrer DN; Pacholski IL; Zanatta N; Martins MA; Bonacorso H; Morsch VM
J Inorg Biochem; 2005 Sep; 99(9):1853-7. PubMed ID: 16098596
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs.
Yokel RA; Ackrill P; Burgess E; Day JP; Domingo JL; Flaten TP; Savory J
J Toxicol Environ Health; 1996 Aug; 48(6):667-83. PubMed ID: 8772805
[TBL] [Abstract][Full Text] [Related]
9. 1,6-Dimethyl-4-hydroxy-3-pyridinecarboxylic acid and 4-hydroxy-2-methyl-3-pyridinecarboxylic acid as new possible chelating agents for iron and aluminium.
Dean A; Ferlin MG; Brun P; Castagliuolo I; Yokel RA; Badocco D; Pastore P; Venzo A; Bombi GG; Di Marco VB
Dalton Trans; 2009 Mar; (10):1815-24. PubMed ID: 19240917
[TBL] [Abstract][Full Text] [Related]
10. Combined chelation based on glycosyl-mono- and bis-hydroxypyridinones for aluminium mobilization: solution and biodistribution studies.
Chaves S; Dron PI; Danalache FA; Sacoto D; Gano L; Santos MA
J Inorg Biochem; 2009 Nov; 103(11):1521-9. PubMed ID: 19748126
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 2-methyl-3-hydroxy-4-pyridinecarboxylic acid as a possible chelating agent for iron and aluminium.
Dean A; Ferlin MG; Brun P; Castagliuolo I; Badocco D; Pastore P; Venzo A; Bombi GG; Di Marco VB
Dalton Trans; 2008 Apr; (13):1689-97. PubMed ID: 18354766
[TBL] [Abstract][Full Text] [Related]
12. Aluminum determination in biological fluids and dialysis concentrates via chelation with 8-hydroxyquinoline and solvent extraction/fluorimetry.
Buratti M; Valla C; Pellegrino O; Rubino FM; Colombi A
Anal Biochem; 2006 Jun; 353(1):63-8. PubMed ID: 16643833
[TBL] [Abstract][Full Text] [Related]
13. Bis(3-hydroxy-4-pyridinone)-EDTA derivative as a potential therapeutic Al-chelating agent. Synthesis, solution studies and biological assays.
Santos MA; Gama S; Gano L; Farkas E
J Inorg Biochem; 2005 Sep; 99(9):1845-52. PubMed ID: 16099511
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute and chronic coingestion of AlCl3 with citrate or polyphenolic acids on tissue retention and distribution of aluminum in rats.
Deng Z; Coudray C; Gouzoux L; Mazur A; Rayssiguier Y; Pépin D
Biol Trace Elem Res; 2000 Sep; 76(3):245-56. PubMed ID: 11049223
[TBL] [Abstract][Full Text] [Related]
15. New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
Grazina R; Gano L; Sebestík J; Amelia Santos M
J Inorg Biochem; 2009 Feb; 103(2):262-73. PubMed ID: 19062099
[TBL] [Abstract][Full Text] [Related]
16. Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration.
Canteros-Picotto A; Fernández-Martín JL; Cannata-Andía JB
Am J Kidney Dis; 2000 Nov; 36(5):969-75. PubMed ID: 11054353
[TBL] [Abstract][Full Text] [Related]
17. Coordination studies of Al-EDTA in aqueous solution.
Coskuner O; Jarvis EA
J Phys Chem A; 2008 Mar; 112(12):2628-33. PubMed ID: 18293948
[TBL] [Abstract][Full Text] [Related]
18. Aluminum-induced maternal and developmental toxicity and oxidative stress in rat brain: response to combined administration of Tiron and glutathione.
Sharma P; Mishra KP
Reprod Toxicol; 2006 Apr; 21(3):313-21. PubMed ID: 16040227
[TBL] [Abstract][Full Text] [Related]
19. Aluminium leaching using chelating agents as compositions of food.
Karbouj R
Food Chem Toxicol; 2007 Sep; 45(9):1688-93. PubMed ID: 17434655
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of Al maltolate-induced neurodegeneration with subsequent Al removal by desferrioxamine treatment.
Huang Y; Savory J; Herman MM; Nicholson JR; Reyes MR; Boyd JC; Wills MR
Neurotoxicology; 1995; 16(2):291-6. PubMed ID: 7566688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
